Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2
- PMID: 26869767
- PMCID: PMC4737557
- DOI: 10.2147/DDDT.S98466
Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2
Abstract
It is recognized that myeloid differentiation protein 2 (MD-2), a coreceptor of toll-like receptor 4 (TLR4) for innate immunity, plays an essential role in activation of the lipopolysaccharide signaling pathway. MD-2 is known as a neoteric and suitable therapeutical target. Therefore, there is great interest in the development of a potent MD-2 inhibitor for anti-inflammatory therapeutics. Several studies have reported that xanthohumol (XN), an anti-inflammatory natural product from hops and beer, can block the TLR4 signaling by binding to MD-2 directly. However, the interaction between MD-2 and XN remains unknown. Herein, our work aims at characterizing interactions between MD-2 and XN. Using a combination of experimental and theoretical modeling analysis, we found that XN can embed into the hydrophobic pocket of MD-2 and form two stable hydrogen bonds with residues ARG-90 and TYR-102 of MD-2. Moreover, we confirmed that ARG-90 and TYR-102 were two necessary residues during the recognition process of XN binding to MD-2. Results from this study identified the atomic interactions between the MD-2 and XN, which will contribute to future structural design of novel MD-2-targeting molecules for the treatment of inflammatory diseases.
Keywords: binding mode; inflammation; molecular dynamics simulation; myeloid differentiation 2; xanthohumol.
Figures
Similar articles
-
Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2).Planta Med. 2010 Oct;76(14):1536-43. doi: 10.1055/s-0029-1241013. Epub 2010 Mar 22. Planta Med. 2010. PMID: 20309792
-
Insights into the binding mode of curcumin to MD-2: studies from molecular docking, molecular dynamics simulations and experimental assessments.Mol Biosyst. 2015 Jul;11(7):1933-8. doi: 10.1039/c5mb00085h. Mol Biosyst. 2015. PMID: 25923908
-
Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages.Int Immunopharmacol. 2008 Apr;8(4):567-73. doi: 10.1016/j.intimp.2007.12.017. Epub 2008 Jan 24. Int Immunopharmacol. 2008. PMID: 18328448
-
Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.Pharmacol Ther. 2012 Mar;133(3):291-8. doi: 10.1016/j.pharmthera.2011.11.001. Epub 2011 Nov 19. Pharmacol Ther. 2012. PMID: 22119168 Review.
-
Potential Roles of Myeloid Differentiation Factor 2 on Neuroinflammation and Its Possible Interventions.Mol Neurobiol. 2020 Nov;57(11):4825-4844. doi: 10.1007/s12035-020-02066-2. Epub 2020 Aug 15. Mol Neurobiol. 2020. PMID: 32803490 Review.
Cited by
-
Novel insights into whey protein among Yak, Yellow Cattle, and Cattle-Yak milk.Food Chem X. 2024 Apr 16;22:101384. doi: 10.1016/j.fochx.2024.101384. eCollection 2024 Jun 30. Food Chem X. 2024. PMID: 38681228 Free PMC article.
-
Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis.Rheumatology (Oxford). 2024 Mar 1;63(3):608-618. doi: 10.1093/rheumatology/kead493. Rheumatology (Oxford). 2024. PMID: 37788083 Free PMC article. Review.
-
Immunohistochemical Localization of MD2, a Co-Receptor of TLR4, in the Adult Mouse Brain.ACS Chem Neurosci. 2023 Feb 1;14(3):400-417. doi: 10.1021/acschemneuro.2c00540. Epub 2023 Jan 19. ACS Chem Neurosci. 2023. PMID: 36657737 Free PMC article.
-
Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches.Molecules. 2022 Jul 5;27(13):4319. doi: 10.3390/molecules27134319. Molecules. 2022. PMID: 35807562 Free PMC article.
-
HSP60-Derived Peptide as an LPS/TLR4 Modulator: An in silico Approach.Front Cardiovasc Med. 2022 Apr 1;9:731376. doi: 10.3389/fcvm.2022.731376. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35433873 Free PMC article.
References
-
- Hecht G. Innate mechanisms of epithelial host defense: spotlight on intestine. Am J Physiol. 1999;277(3 Pt 1):C351–C358. - PubMed
-
- Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340(2):115–126. - PubMed
-
- Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179(1):80–86. - PubMed
-
- Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939–949. - PubMed
-
- Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453–461. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources